Anticholesterolemic and Antiatherogenic Effects of Taurine Supplementation is Model Dependent by Eilertsen, Karl-Erik et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 11 
 
 
 
 
© 2012 Eilertsen et al., licensee InTech. This is an open access chapter distributed under the terms of the 
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
Anticholesterolemic and Antiatherogenic Effects 
of Taurine Supplementation is Model Dependent 
Karl-Erik Eilertsen, Rune Larsen,  
Hanne K. Mæhre, Ida-Johanne Jensen and Edel O. Elvevoll 
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/47865 
1. Introduction 
Taurine (2-aminoethanesulfonic acid) is a sulphur-containing compound characterized as an 
amino acid. The presence of a sulfonic group, as opposed to a carboxyl group in other amino 
acids, gives taurine a pKa value of 1.5 and it is the most acidic amino acid. It is an 
exclusively free amino acid, i.e. it is not incorporated into proteins, but still widely 
distributed in most body tissues.  
 
Figure 1. The structure of taurine 
Taurine was identified almost two centuries ago and was named after the ox, Bos taurus, 
since it was first isolated from the bile of ox [1]. After its discovery, taurine was considered 
non-essential and biologically inert, however a multitude of functions have now been 
identified. Yet, all its physiological roles have not been fully elucidated. The 
phylogenetically oldest and best documented function of taurine is conjugation with bile 
acids in bile salt synthesis [2, 3]. In addition, taurine is involved in a variety of physiological 
processes as extensively reviewed [2], including neuromodulation in the central nervous 
system [4], energy production [5], protection against oxidation [6, 7] and immunomodulation 
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[8, 9]. An osmoregulatory role of taurine has also been established, playing a pivotal role in 
Central nervous system (CNS) cell volume regulation [10-12]. 
In felines taurine is considered indispensable and dietary deficiency leads to several clinical 
problems, including retinal degeneration and developmental abnormalities [13]. In humans 
it is regarded as a conditionally essential amino acid due to a limited ability to synthesize it 
[14, 15]. Taurine is now thought to play a more important role in human nutrition, and an 
increased dietary intake of taurine has been linked to several beneficial health outcomes in 
various diseases and medical conditions [16-18]. 
2. Taurine and nutrition 
Estimates of dietary intake of taurine vary greatly. Although taurine content have been 
analysed in a variety of foods, it is usually excluded in food and nutrition data banks. Therefore, 
it is difficult to assess the dietary intake. A diet high in meat and especially seafood will provide 
a higher intake than a vegetarian diet which will provide very little taurine [19]. Mean ± SE 
dietary intake of taurine of 58 ± 19.5 mg/d was reported in omnivores [20], while it was not 
detected in a vegan diet. Laidlaw et al. [21] analysed taurine content in foods and calculated a 
taurine intake of less than 200 mg/d for individuals consuming a diet high in meat.  
2.1. Taurine biosynthesis 
Taurine is the most abundant intracellular free amino acid in the human body, the average 
amount being approximately 560 mmol (70g). The main organs of distribution are the retina, 
along with white blood cells, platelets, spleen, heart, muscle and brain [22]. 
As a product in the metabolism of sulphur-containing amino acids, taurine can be 
synthesised from its precursors methionine and cysteine, as shown in figure 2. The first step 
of the synthesis is methionine’s reversible conversion to homocysteine by transmethylation 
and remethylation processes. Homocysteine can then be converted irreversibly to cysteine 
through the transsulfuration pathway catalyzed by cystathionine β-synthase and 
cystathionine γ-lyase [23]. Cysteine is, in turn, the origin of several biologically important 
molecules, including glutathione, inorganic sulphur and taurine [24]. Taurine can be 
synthesised from cysteine through several pathways, most commonly via cysteine sulfinic 
acid and hypotaurine, involving the enzymes cysteine dioxygenase (CDO) and cysteine 
sulfinic decarboxylase (CSAD) mainly present in the liver and brain. The activities of the 
enzymes involved, in particular the activity of CSAD, are both species and age dependent 
[25-27], being high in rodents and absent in cats. In addition, taurine synthesis is dependent 
on an adequate cysteine concentration, as production of glutathione is favoured when 
cysteine concentration is limited [28]. 
In humans the CSAD activity is low and the average daily synthesis of taurine ranges from 
0.4 to 1.0 mmol (50-125mg). Excretion of taurine is very variable (0.22-1.85 mmol day-1) and 
affected by several factors such as genetics, age, gender, dietary intake, kidney function and 
health status [22]. The taurine body pool size is however regulated by the kidneys through 
renal absorption by the proximal tubule [14, 26, 29, 30]. 
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Figure 2. Taurine biosynthesis 
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2.2. Dietary sources 
Taurine is found in most meats used for human consumption, whereas plants including 
grains, legumes, fruits and vegetables are devoid or contain only negligible amounts [21]. 
An exception is algae, mainly red algae (Rhodophyta), where notable amounts have been 
found [31, 32]. 
Taurine concentration has been investigated in a wide range of food products and it varies 
substantially between different marine and non-marine food items [17, 33]. A comparison of 
taurine concentrations in various foods is presented in table 1 [21, 34-43]. It is evident that 
seafood, and especially molluscs are high in taurine. Taurine is a key osmolyte in marine 
molluscs [44] and the highest taurine concentrations are found in marine bivalves and 
univalves [45]. Scallops and blue mussels are reported to have a respective taurine content 
of 827±15 and 510±12 mg per 100g raw muscle [21, 34]. In fact, the univalve abalone was 
already early in the last century 1918 exploited for preparation of taurine in large quantities 
[46]. 
There is also a tendency of taurine being more abundant in fish than in terrestrial animals. 
Taurine concentrations (mg per 100g raw fillets) of entire muscle of farmed Atlantic 
salmon (94 ± 16 mg), cod (120 ± 21 mg), saithe (162 ± 25 mg) and haddock (57 ± 6 mg) are 
reported to be intermediate [34]. Taurine content varies greatly between white and red 
muscle both in fish, poultry and mammals, with significantly higher levels being present 
in red muscle [21, 39, 40, 43], probably due to the increased vascularisation of these 
tissues.  
Several studies investigating the retention and losses of taurine during food processing and 
preparation have been conducted [34, 36, 47-49]. Results indicate that taurine is susceptible 
to leaching losses similar to or even more than other free amino acids. Data on the oxidative 
and heat stability of taurine in foods is scarce. In milk, taurine losses seemed to proceed with 
the same degradation rate as lysine due to browning reactions [50]. 
2.3. Taurine supplementation 
Taurine is maybe most famous for being an ingredient that is added to energy drinks, the 
concentration being approximately 4.0 g/L. Its physiological effect has been debated, with 
manufacturers, backed by studies, claiming that taurine in combination with other active 
ingredients may improve cognitive and muscular performance [51, 52]. The safety of taurine 
intake has also been investigated, especially in conjunction with its use in energy drinks. 
The European Food Safety Authority (EFSA) have concluded that taurine do not present any 
safety concerns with the levels currently used in energy drinks. The no observable adverse 
effect level (NOAEL) was at least 1000 mg/kg bw/day for pathological and behavioural 
changes, being much higher than an extreme consumer would be exposed to [53]. In their 
risk assessment, Shao and Hatchcock [54], found that absence of adverse effects was strong 
for taurine at supplemental intakes up to 3 g per day.  
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Food source 
Taurine content
(mg/100g wet weight) 
reported range ± SEM 
References 
Meat   
Beef, round 36 [38] 
Beef (Bos taurus) 43 ± 8 [21] 
Chicken, light meat 18 ± 3 [21] 
Chicken, dark meat 169 ± 37 [21] 
Turkey, light meat 30 ± 7 [21] 
Turkey, dark meat 306 ± 69 [21] 
Pork (loin) 61 ± 11 [21, 38] 
Pork (loin) 50 ± 11 [21, 38] 
Lamb, leg 45 ± 4 [38] 
Veal 40 ± 13 [21] 
Reindeer (loin) 62,4 ± 12 [42] 
Red deer (loin) 28 ± 13 [37] 
   
Fish   
Plaice 146 ± 5 [[35] 
Cod fillet 120 ± 21 [34, 48] 
Cod roe 365 [34] 
Saithe fillet 162  ± 25 [34] 
Haddock fillet 57  ± 6 [34] 
African catfish 201  ± 32 [36] 
Salmon fillet 94  ± 16 [34] 
Mackerel 78 [35] 
Bigeye tuna, white muscle 26 [41] 
Bigeye tuna, dark muscle 270 [41] 
Yellowfin tuna, white muscle 42 [41] 
Yellowfin tuna, dark muscle 964 [41] 
Bluefin tuna, white muscle 88 [41] 
Bluefin tuna, dark muscle 195 [41] 
Pacific saury, white muscle 223 [41] 
Pacific saury, dark muscle 248 [41] 
Milkfish, white muscle 95,7 [39] 
Milkfish, dark muscle 309 [39] 
Octopus 388 ± 13 [43] 
Squid 356 ± 95 [21] 
   
Fresh water fish   
Rainbow trout, white muscle 17 [40] 
Rainbow trout, dark muscle 206 [40] 
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Coho salmon, white muscle 23 [40] 
Coho salmon, dark muscle 275 [40] 
Eel, white muscle 7 [40] 
Eel, dark muscle 65 [40] 
Catfish, white muscle 193 [40] 
Catfish, dark muscle 465 [40] 
Tilapia, white muscle 75 [40] 
Tilapia, dark muscle 649 [40] 
Carp, white muscle 129 [40] 
Carp, dark muscle 579 [40] 
Char, white muscle 15 [40] 
Char, dark muscle 190 [40] 
Sweet smelt, white muscle 137 [40] 
Sweet smelt, dark muscle 294 [40] 
   
Shellfish   
Peeled shrimps (Northern) 220 ± 2 [34] 
Blue mussels 510 ± 12 [34] 
Mussel 655 ± 72 [21] 
Mussel 349 [43] 
Clams 520 ± 97 [21, 43] 
Scallops 827 ± 15 [21] 
Scallop 332 [43] 
Oysters 396 ± 29 [21] 
Table 1. Taurine content in various food sources 
Another food item where taurine is supplemented is in infant formulas. This practice started 
in the early 1980s after recognizing that preterm infants fed infant formulas had lower urine 
and plasma concentrations than infants fed pooled human milk [55]. The necessity of this 
supplementation remains disputed as clinical studies have not provided evidence of any 
clinical effects of growth and development in preterm or low birth weight infants [56]. High 
concentrations of taurine in the developing brain [57], as well as results from various animal 
studies clearly indicate the importance of taurine in neurodevelopment [58, 59].  
2.4. Taurine and associated health benefits 
An increased dietary intake of taurine has been associated with multiple beneficial 
health outcomes. Epidemiological data and animal studies suggests that dietary intake of 
taurine has beneficial effects on cardiovascular disease (CVD) [33, 60-62]. Perhaps the 
best characterized attribution of taurine is the antihypertensive effect although there are 
still questions about the exact mechanisms of action [63-66]. A long term effect of 
hypertension is the development of hypertrophy of the left ventricle, in which 
Angiotensin II (Ang II) plays an important role. Several studies have shown that taurine 
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reverses these actions of Ang II [67, 68]. Animal studies have also indicated that taurine 
may reduce insulin resistance [69, 70], but  most of the clinical studies have failed to 
prove the beneficial role of taurine in insulin resistance and diabetic complications [71, 
72]. Taurine have also been found to ameliorate alcoholic steatohepatitis [73-75] in rats. 
In addition, some evidence have been brought forward of a potential therapeutic use of 
taurine in nonalcoholic fatty liver disease [76]. Despite taurine being linked to beneficial 
health outcomes in an increasing number of diseases and medical conditions, the number 
of studies is relatively small. The effects of taurine on cholesterol and CVD are most 
studied and documented.   
3. Taurine and cholesterol metabolism 
Perhaps the best studied function of taurine is its role in cholesterol metabolism. Cholesterol 
is metabolized and broken down to cholic acids, conjugated to taurine or glycine, and 
excreted in the bile [77].  
3.1. Effects of taurine on circulating cholesterol levels 
High blood cholesterol levels is the most pronounced risk factor for developing 
atherosclerosis, vascular inflammation and hardening of the arteries associated with excess 
cholesterol deposition in the vasculature. Taurine has generally been associated with a 
beneficial effect on blood cholesterol levels. Cholesterol is metabolized and broken down to 
cholic acids, conjugated to taurine or glycine, and excreted in the bile [77]. The conjugation 
pattern varies considerably across species. In dog and rat bile acids are entirely conjugated 
to taurine, whereas rabbits have all their bile acids conjugated to glycine. Species where 
glycine-conjugated bile acids dominate have higher blood cholesterol levels and are more 
susceptible to dietary induced hypercholesterolemia, and based on these observations it was 
hypothesized that dietary taurine might counteract dietary induced increase in blood 
cholesterol  [2].  
3.1.1. Effects of taurine on cholesterol levels in mice 
Several studies have investigated the effect of dietary intake of taurine on lipids in different 
mice strains. Six months administration of 1% taurine (w/v) to the drinking water given to 
C57BL7/6J mice fed a high-fat diet resulted in reduced serum LDL and VLDL cholesterol 
and increased serum HDL cholesterol  [78]. Similar results were obtained in a small study 
using the same mouse strain, where 1% taurine (w/w) added to a high cholesterol diet 
reduced serum triglycerides, total cholesterol and VLDL+LDL cholesterol levels already 
after 4 weeks treatment [79]. Cholesterol-fed and streptozotocin (STZ)-induced diabetic male 
ICR mice were given a diet enriched with 2% cholesterol (w/w) and 0.5% cholate (w/w) for 
10 weeks  [80]. In addition, mice received a daily dose of saline or taurine (50 or 100 mg/kg 
p.o.). Both taurine-treated groups had lower serum total and LDL cholesterol compared to 
the STZ/saline group.  
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In more extreme models such as apolipoprotein E-deficient (apoE-/-) mice fed a normal 
rodent chow supplemented with 2% taurine (w/w) for 12 weeks, serum VLDL, LDL and 
total cholesterol levels increased compared to mice without taurine supplementation [81]. 
Similar results has been reported for extreme spontaneously hyperlipidemic mice (SHL; 
KOR-Apoeshl), where 12 weeks treatment with 1% taurine (w/v) added to the drinking water 
increased serum HDL-cholesterol but did not affect serum total cholesterol or VLDL+LDL 
cholesterol levels  [82]. 
3.1.2. Effects of taurine on cholesterol levels in rats 
A large number of studies have investigated the effect of dietary taurine on dietary 
hypercholesterolemia in various rat models [65]. Rats fed high-fat diets seem to be the 
model with most consistent antihypercholesterolemic effects of dietary taurine. Rats have a 
relatively low taurine content in skeletal muscles (10-25 mg/100 g muscle) [83, 84]. 
Rats are generally not suitable for pharmacologically cholesterol and lipoprotein studies due 
to their substantially different lipid profile compared to humans. 
Male wistar rats. Taurine supplementation does not alter plasma lipids in male wistar rats fed 
normal chow [85]. However, when these rats were fed high cholesterol diet containing 2% 
cholesterol and 1% cholic acid, dietary supplementation of 4% taurine significantly 
counteracted the observed increase in serum cholesterol by 44% [86]. This observation has 
been confirmed be several studies [87-90]. In Wistar male rats fed a cholesterol-containing diet 
(0.5% cholesterol w/w) for 40 days, serum cholesterol increased 5 fold compared to chow fed 
rats. Oral supplementation of 470 mg/kg/day taurine (0.5% w/v) in water lowered the 
increased serum cholesterol (54%) [91]. When these rats were fed a high-fat diet (11% coconut 
oil w/w) for 6 months, a daily oral supplementation of 1 mg taurine lowered serum cholesterol 
(37%), LDL cholesterol (34%), and triglycerides (95%), compared to the high-fat control diet 
[88]. Already after 14 days intervention, 5% dietary taurine (w/w) supplementation has been 
indicated to lower high cholesterol (1% cholesterol, 2.5% cholate) induced serum cholesterol (-
42%) [90]. In wistar rats, the taurine effect has been indicated to be caused by an increased 
faecal bile acid excretion, increased hepatic cholesterol 7α-hydroxylase expression and activity 
[89, 90]. The rapid effect of taurine supplementation on serum cholesterol has been confirmed 
recently  [92]. When fed a diet containing 60.7% sucrose, 9.0% lard, and 0.5% cholesterol for 14 
days, serum cholesteryl ester and free cholesterol were reduced by 39% and 53% compared to 
rats fed control diet without taurine, respectively. Rats fed taurine also had smaller livers 
compared to control-fed rats. Hepatic cholesteryl esters were also reduced by approximately 
20% in the taurine supplemented rats. This hypocholesterolemic effect was ascribed to a lower 
hepatic secretion of cholesteryl esters.   
Streptozotocin-induced diabetic rats. Male Wistar rats injected with STZ are also used as a 
diabetic model. In these rats dietary taurine supplementation markedly reduced serum total 
cholesterol (-50%) induced by cholesterol-containing diet (1% cholesterol w/w) for 4 weeks 
[93].  
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Fructose-induced rat insulin resistance model. Male wistar rats fed a diet containing 60% 
fructose developed impaired glucose tolerance and insulin resistance [85]. Taurine 
administration (300 mg/kg/day i.p.) counteracted the fructose induced plasma total 
cholesterol, LDL cholesterol, and triglycerides by 11%, 21%, and 23%, respectively.  
Spontaneously hypertensive rats (SHR). The effect of taurine supplementation on blood 
pressure in SHR rats was investigated already in the 1970ies [94]. How dietary 
administration of taurine affects cholesterol metabolism has not been reported in these 
studies. However, in a stroke-prone substrain of the SHR rats, taurine supplementation has 
been indicated to prevent high-fat/high cholesterol induced elevation of serum cholesterol in 
SHR rats [95].  
Sprague-Dawley rats. Also in male Sprague-Dawley rats fed a high-fat, high cholesterol diet 
(HFCD; 10% corn oil, 1.5% cholesterol) supplemented with taurine (1.5% w/w) plasma 
cholesterol was lowered by 31% compared to HFCD control rats  [87]. LDL+VLDL 
cholesterol (-38%) and triglycerides (-43%) were also lower in rats supplemented with 
taurine compared to HFCD control rats. These results have been confirmed with an identical 
experimental setup for 5 weeks reporting a 20% and 25% reduction in serum total 
cholesterol and triglycerides, respectively [96]. In this model, plasma total cholesterol, LDL 
cholesterol and triglycerides were reduced in rats fed taurine supplemented cholesterol free 
diet compared the cholesterol free control diet  [87].  
3.1.3. Effects of taurine on cholesterol levels in rabbits 
Different rabbit strains have been used to investigate the effects of dietary taurine 
supplementation on dietary induced hypercholesterolemia [86, 97, 98]. The results from the 
administration of taurine to rabbits have been ambiguous. In Male New Zealand white rabbits, 
fed a high cholesterol (1% w/w) diet, addition of 2.5% taurine (w/w)  for 2.5 month reduced 
the serum total cholesterol and triglyceride levels by 22% and 38%, respectively, compared 
to high cholesterol diet alone [99]. In this study similar reductions were observed for hepatic 
and aorta lipid levels in these rabbits. However, when the same rabbit strain were given 
normal chow supplemented with 0.5% cholesterol (w/w)  for 4 weeks no effect of dietary 
taurine (2.5% w/w) supplementation was observed  [100]. Also when given a normal diet 
supplemented with 2% cholesterol (w/w), taurine added to the drinking water (0.1 or 0.5% 
w/v) for 14 weeks had no influence on serum cholesterol and triglycerides [97]. 
3.1.4. Effects of taurine on cholesterol levels in hamsters 
Hamsters (Male Golden Syrian hamsters) have also been used as model for studying 
cholesterol metabolism. The rationale for this is that hamsters and humans have comparable 
blood cholesterol levels, hamsters use both taurine and glycine for bile acid conjugation and 
the lipoprotein profile in response to dietary cholesterol is comparable  [101]. When Male 
Golden Syrian hamsters were fed a normal chow supplemented with 0.05% cholesterol or a 
10% coconut oil, high-fat diet (0.05% cholesterol) for two weeks, taurine dissolved in 
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drinking water (1% w/v) reduced serum total cholesterol in chow- (15% reduction) as well 
as high-fat diet-fed (42% reduction) hamsters [102]. A similar effect was observed for non-
HDL (LDL+VLDL) cholesterol.  
Recently, lipid metabolism has been closely studied in Male Golden Syrian Hamsters fed 
different diets with or without taurine for 4 weeks  [103]. The groups received a high fat diet 
(chow mixed with 7% butter [w/w] and 0.2% cholesterol [w/w]) and drinking water without 
or supplemented with either 0.35% or 0.7% taurine (w/v). Hamsters given taurine was 
smaller, had less visceral fat and smaller livers after 4 weeks. Both taurine concentrations 
resulted in significant lower serum triglycerides, total cholesterol, and LDL+VLVL 
cholesterol. Up-regulated gene expression of the low-density lipoprotein receptor and 
CYP7A1 genes, paralleled by increased faecal cholesterol and bile acid concentrations in the 
taurine treated hamsters, indicated that the taurine effect on the cholesterol and lipid 
profiles is due to increased cholesterol metabolism.  
3.1.5. Effects of taurine on cholesterol levels in humans 
Historically, taurine has been believed to decrease blood cholesterol levels in adults. Only 
a limited number of studies have investigated the effect of oral taurine supplementation 
on blood cholesterol or lipoprotein levels in humans and ambiguous results have arisen 
from these. Early studies found no effect on serum cholesterol after incidental treatment 
of patients with 1.5 to 3 g taurine/day for up to 2 months [77, 104, 105]. To our knowledge 
there has been no well-designed random controlled clinical trial assessing the dose-
response effect of oral taurine supplementation on blood lipids in healthy humans. 
However, the effect of taurine in relation to development of CVD has been documented 
through a human clinical trial. Results of a 7 week human intervention trial revealed that 
supplementation with 0.4 g taurine/day in combination with omega-3 fatty acids (1 g 
EPA+DHA/day) significantly improved the lipid profiles by reducing serum total and 
LDL cholesterol levels compared to supplementation with omega-3 fatty acids alone  
[106]. In another study the effects of oral supplementation with taurine (3 g/day) or 
placebo for 7 weeks was assessed in young obese healthy subjects  [107]. In this study, 
taurine had no effect on serum cholesterol, but triglycerides and bodyweight was 
significantly reduced compared to placebo effect. Finally, a daily 6 g taurine 
supplementation to human healthy volunteers receiving a cholesterol-inducing diet for 3 
weeks attenuated the expected increase of serum total cholesterol and LDL-cholesterol, 
whereas serum VLDL-cholesterol and triglyceride levels compared to the control group 
[108]. In insulin-dependent diabetes mellitus patients intake of taurine (1 g/day) reduced 
serum triglyceride levels, but no effect was observed on serum cholesterol [109]. Finally, 
in a randomized, double-blinded, crossover intervention, overweight non-diabetic men 
given a daily dose of 1.5 g taurine or placebo, no effect was reported on blood lipids  [71]. 
In summary, results from oral taurine supplementation to humans are ambiguous, and 
further adequately designed interventions are warranted to further investigate the 
potential of taurine as a hypocholesterolemic agent.  
 
Anticholesterolemic and Antiatherogenic Effects of Taurine Supplementation is Model Dependent 279 
4. Effects of taurine on atherogenesis/development of atherosclerosis 
High blood cholesterol levels is the most pronounced risk factor for developing 
atherosclerosis, vascular inflammation and hardening of the arteries associated with excess 
cholesterol deposition in the vasculature. Apart from humans and monkeys, wild animals 
normally do not develop substantial atherosclerosis. There is however, an array of 
laboratory animal models in common use for studying the effects of pharmacological 
substances and dietary modifications on lesion formation. The effect of taurine has been 
investigated in several of these models. 
4.1. Effects of taurine on atherosclerosis in mice 
In the hyperlipidemic apoE-/- mice, taurine has been reported to delay atherogenesis by 
decreasing oxidized substances that cause inflammation, as well as increasing HDL-
cholesterol  [82]. Also in apoE-/- mice fed a normal rodent chow supplemented with 2% 
taurine (w/w) for 12 weeks, formation of atherosclerotic lesions were significantly reduced 
[81]. However this effect was independent of serum cholesterol as VLDL, LDL, and total 
cholesterol were increased.  
Moreover, in spontaneously hyperlipidemic mice, taurine (1% w/v) provided through 
drinking water, was reported to suppress the development of lesion formation without 
affecting the levels of serum VLDL and LDL [82]. 
In our lab, apoE-/--mice were given Western diets (WD) containing 20% fat (w/w), 0.2%  
cholesterol (w/w) for 13 weeks [110]. The mice received WD, WD supplemented with 0.5% 
taurine (w/w) or WD supplemented with 0.5% taurine (w/w) in combination with a daily 
dose of marine long-chain omega-3 polyunsaturated fatty acids (n-3 PUFA) recommend in 
the dietary guidelines for humans. In these studies, taurine did not affect serum cholesterol 
or triglyceride levels alone or combination with n-3 PUFA. This may indicate that a larger 
supplementary dose of taurine is needed to prevent dietary induced hypercholesterolemia 
in apoE-/--mice. 
4.2. Effects of taurine on lipid lesion formation in rats 
Rats are generally not a suitable animal model for atherosclerosis as they do not develop 
lesion deposits resembling the early phase of human atherogenesis. However, in a rat model 
of balloon induced vascular neointima formation, supplementation with taurine (3% in 
drinking water) from 2 days before the surgical procedure and 14 days after, reduced 
vascular smooth muscle cell proliferation [111]. This key step in the initiation of 
atherogenesis was reduced by 28% compared to control fed rats. Taurine was located 
immunohistochemically mainly to the surface of the exposed media and adventitia of the 
injured carotid artery and higher levels were observed in the taurine treated rats. This 
corresponded to a lower vascular production of superoxide anion compared to the control 
animals. From these experiments it was concluded that the preventive effect of taurine 
towards neointima formation was attributable to anti-oxidative effects. 
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4.3. Effects of taurine on atherosclerosis in rabbits 
The effect of dietary taurine on development of atherosclerosis has been investigated in 
different rabbit strains. Taurine has been indicated to prevent progression of 
atherosclerotic lesions in rabbits without affecting serum cholesterol in two different 
models. In New-Zealand white male rabbits given a diet containing 2% cholesterol (w/w), 
taurine added to the drinking water (0.1 or 0.5% w/v) for 14 weeks reduced the aortic 
deposition of fat [97]. This so-called anti-atherosclerotic effect was only significant for the 
highest taurine dose tested. Recently, it was indicated that the taurine antiatherosclerotic 
effect was evident in these rabbits after only 4 weeks on the atherogenic diet [100]. 
Watanabe heritable hyperlipidemic (WHHL) rabbits carries an inheritable mutation in the LDL 
receptor and is hence a typical genetically hyperlipidemic animal model. When WHHL 
rabbits were given drinking water containing 1% taurine (w/v) for 6 months they 
developed significantly less atherosclerotic lesion formation compared to rabbits not 
supplemented with taurine [112]. 
4.4. Effects of taurine on atherosclerosis in humans 
Results on the effects of dietary taurine in humans are mainly from prospective studies. It is 
evident that individuals with high urinary excretion of taurine and high dietary intake of 
food high in taurine in general have fewer incidences of cardiovascular diseases compared 
to individuals with low dietary intake of taurine [33]. In addition, increased dietary intake of 
taurine either alone or in the combination with omega-3 fatty acids, has also been suggested 
to reduce MCP-1, an important risk factor of CVD  [106]. No further randomised clinical 
trials on the effects of dietary supplementation of taurine on CVD disease markers has been 
reported. 
5. Conclusion 
Taurine appears to be able to prevent hypercholesterolemia and hepatic steatosis induced by 
high-fat and high-cholesterol diets in most animal models. The major mechanism by which 
taurine lowers serum cholesterol levels is by increased utilization of cholesterol for bile acid 
synthesis. In mice, rats, and hamsters, dietary intake of taurine cause reduction in diet-
induced serum cholesterol accompanied by enhanced mRNA expression and enzymatic 
activity of 7a-hydroxylase, the rate-limiting enzyme of bile acid synthesis. In normal diets 
taurine does not appear to modify serum and liver cholesterol levels.  
Dietary supplementation with taurine is indicated to have cardiovascular benefits. The effect 
on atherosclerosis appears to be highly dose- and model-dependent. In animal experiments 
using high-fat diets to induce increased levels of lipids, taurine has been demonstrated to 
significantly alleviate atherosclerotic lesions. The effects of taurine appear to be related to 
increased degradation and excretion of cholesterol as bile in the feces and the most common 
feature is that taurine increases expression and activity of cholesterol 7α-hydroxylase. Only 
a few studies have evaluated the effects of taurine in human subjects.  
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From the available data it is not possible to conclude about the proposed antihyperlipidemic 
and antiatherosclerotic, therefore more basic and clinical research on the effects of taurine 
supplementation on hypercholesterolemic and atherosclerotic effects are warranted. 
Randomized clinical trials of dietary taurine and taurine sources may provide further 
knowledge about the potential hypocholesterolemic and antiatherogenic effects of long-term 
dietary taurine supplementation in healthy volunteers and humans with hyperlipidemia, 
metabolic syndrome and cardiovascular diseases.  
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